Merck (MRK) Share-based Compensation (2009 - 2026)
Merck's Share-based Compensation was $298 million in Q2 2026, up 38.0% from $216 million a year earlier and up 61.1% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Share-based Compensation (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Merck's Share-based Compensation was $892 million through Jun 30, 2026, up 12.5% year-over-year; for FY2025, it came in at $820 million, up 7.8% from FY2024.
- Share-based Compensation has now increased for 12 consecutive years, with a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $761 million in FY2024 (+18.0%), $645 million in FY2023 (+19.2%), $541 million in FY2022 (+12.9%) and $479 million in FY2021 (+8.6%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2009.
- Compared with a year earlier, Share-based Compensation was higher in seven of the last eight quarters, with growth averaging 11.9%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2026 (growth of 38.0%); the worst was Q3 2021 (a decline of 7.1%).
- Per Business Quant data, MRK's Share-based Compensation in the three quarters before Q2 2026 was $185 million (Q1 2026), $205 million (Q4 2025) and $204 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 298.00 Mn |
| Mar 31, 2026 | 185.00 Mn |
| Dec 31, 2025 | 205.00 Mn |
| Sep 30, 2025 | 204.00 Mn |
| Jun 30, 2025 | 216.00 Mn |
| Mar 31, 2025 | 195.00 Mn |
| Dec 31, 2024 | 187.00 Mn |
| Sep 30, 2024 | 195.00 Mn |
| Jun 30, 2024 | 203.00 Mn |
| Mar 31, 2024 | 176.00 Mn |
| Dec 31, 2023 | 167.00 Mn |
| Sep 30, 2023 | 164.00 Mn |
| Jun 30, 2023 | 169.00 Mn |
| Mar 31, 2023 | 145.00 Mn |
| Dec 31, 2022 | 145.00 Mn |
| Sep 30, 2022 | 139.00 Mn |
| Jun 30, 2022 | 137.00 Mn |
| Mar 31, 2022 | 120.00 Mn |
| Dec 31, 2021 | 119.00 Mn |
| Sep 30, 2021 | 117.00 Mn |
API Access
Merck Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();